Saturday, November 22, 2008

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
Voltaren cream moves forward in clinical trials

Voltaren cream moves forward in clinical trials

(Lifesciencesworld.com) UPDATED 2007-06-27

Drugmaker Pharmos has announced that its new Voltaren cream to treat osteoarthritis (OA) is moving into Phase II clinical trials. This topical form of the non-steroidal anti-inflammatory drug (NSAID) is designed to deliver a high concentration of the med directly to the OA-affected joint. This could help patients who can't tolerate oral NSAIDs manage their OA pain. Read full story >

See all Rheumatoid Arthritis News

Related: Voltaren

Bookmark

Was this helpful? Yes

Save to My Home
Want to keep this page handy for later? Click Save to My Home and we'll add it to your My Home area.

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2008. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.